Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 413 participants.
Also called NCT02642159
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 413 participants
- Sponsor
- Registry
-
NCT02642159 -
2015-001934-19
-
- Other papers using this trial's data
- Alirocumab vs usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
- Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Türkiye, United Arab Emirates, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02642159. Randomized; no masking; primary purpose treatment. Start 2016-03-15 (registry gives no type); primary completion 2017-03-22 (actual). Results posted on 2018-05-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
- Condition
- Dyslipidemia
- Intervention (Drug)
- Alirocumab
- Intervention (Drug)
- Statins
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Fenofibrate
- Intervention (Drug)
- Nicotinic acid
- Intervention (Drug)
- Omega-3 fatty acids
- Intervention (Drug)
- Antihyperglycemic Drug
- Lead sponsor
- Sanofi
- Collaborator
- Regeneron Pharmaceuticals
Record details
- Record id
cardio:ct-nct02642159- Content hash
e33de44e8de85a35ed01b3c3ebe9e5d1cf03e5c3ff76e9cd861b8e84d2d2ea2f